Concert Pharmaceuticals, Inc.
DEUTERATED MORPHINAN COMPOUNDS FOR TREATING AGITATION

Last updated:

Abstract:

This invention relates to methods of treating agitation comprising administering a morphinan compound or a pharmaceutically acceptable salt thereof. This invention also provides the use in methods of treating agitation and related disorders with such a morphinan compound in combination with quinidine, or pharmaceutically acceptable salt of either or both thereof.

Status:
Application
Type:

Utility

Filling date:

22 Jul 2019

Issue date:

7 Nov 2019